Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

Enfermedad de Parkinson

2343 ARTíCULOS , VIENDO DEL 2311 AL 2325

PUBMED

Latent Cognitive Phenotypes in De Novo Parkinson's Disease: A Person-Centered Approach.

LaBelle DR, Walsh RR, Banks SJ.

J Int Neuropsychol Soc. 2017 Jun 27:1-13. doi: 10.1017/S1355617717000406. [Epub ahead of print]

0

0

0

PUBMED

Pikuni-Blackfeet traditional medicine: Neuroprotective activities of medicinal plants used to treat Parkinson's disease-related symptoms.

de Rus Jacquet A, Tambe MA, Ma SY, McCabe GP, Vest JH, Rochet JC.

J Ethnopharmacol. 2017 Jan 11. pii: S0378-8741(16)30673-0. doi: 10.1016/j.jep.2017.01.001. [Epub ahead of print]

0

0

0

PUBMED

Motor and non-motor symptoms in old-age onset Parkinson's disease patients.

Mendonça MD, Lampreia T, Miguel R, Caetano A, Barbosa R, Bugalho P.

J Neural Transm (Vienna). 2017 Mar 17. doi: 10.1007/s00702-017-1711-1. [Epub ahead of print]

0

0

0

PUBMED

Effect of intranasal stem cell administration on the nigrostriatal system in a mouse model of Parkinson's disease.

Salama M, Sobh M, Emam M, Abdalla A, Sabry D, El-Gamal M, Lotfy A, El-Husseiny M, Sobh M, Shalash A, Mohamed WM.

Exp Ther Med. 2017 Mar;13(3):976-982. doi: 10.3892/etm.2017.4073. Epub 2017 Jan 20.

0

0

0

PUBMED

Altered Functional Brain Connectomes between Sporadic and Familial Parkinson's Patients.

Tang Y, Xiao X, Xie H, Wan CM, Meng L, Liu ZH, Liao WH, Tang BS, Guo JF.

Front Neuroanat. 2017 Nov 6;11:99. doi: 10.3389/fnana.2017.00099. eCollection 2017.

0

0

0

PUBMED

Multiple Evidences for Association between Cognitive Impairment and Dysglycemia in Parkinson's Disease: Implications for Clinical Practice.

Yang L, Chen Z, Li B, Wang M, Yu L, Wan Y, Gan J, Zhang Y, Liu Z, Wang X.

Front Aging Neurosci. 2017 Nov 3;9:355. doi: 10.3389/fnagi.2017.00355. eCollection 2017.

0

0

0

PUBMED

Activation of the mitochondrial unfolded protein response promotes longevity and dopamine neuron survival in Parkinson's disease models.

Cooper JF, Machiela E, Dues DJ, Spielbauer KK, Senchuk MM, Van Raamsdonk JM.

Sci Rep. 2017 Nov 27;7(1):16441. doi: 10.1038/s41598-017-16637-2.

0

0

0

PUBMED

New Drug Approved For Parkinson's Disease.

Aschenbrenner DS.

Am J Nurs. 2017 Jul;117(7):22-23. doi: 10.1097/01.NAJ.0000520942.08729.31. No abstract available.

0

0

0

PUBMED

Cellular models as tools for the study of the role of alpha-synuclein in Parkinson's disease.

Lázaro DF, Pavlou MAS, Outeiro TF.

Exp Neurol. 2017 May 16. pii: S0014-4886(17)30124-3. doi: 10.1016/j.expneurol.2017.05.007. [Epub ahead of print] Review.

0

0

0

PUBMED

Repulsive guidance molecule a (RGMa) induces neuropathological and behavioral changes that closely resemble Parkinson's disease.

Korecka JA, Moloney EB, Eggers R, Hobo B, Scheffer S, Ras-Verloop N, Pasterkamp RJ, Swaab DF, Smit AB, Van Kesteren RE, Bossers K, Verhaagen J.

J Neurosci. 2017 Aug 21. pii: 0084-17. doi: 10.1523/JNEUROSCI.0084-17.2017. [Epub ahead of print]

0

0

0

PUBMED

Comparison of Pallidal and Subthalamic Deep Brain Stimulation in Parkinson's Disease: Therapeutic and Adverse Effects.

Ryu HS, Kim MS, You S, Kim MJ, Kim YJ, Kim J, Kim K, Chung SJ.

J Mov Disord. 2017 May;10(2):80-86. doi: 10.14802/jmd.17001. Epub 2017 May 8.

0

0

0

PUBMED

Classification of advanced stages of Parkinson's disease: translation into stratified treatments.

Krüger R, Klucken J, Weiss D, Tönges L, Kolber P, Unterecker S, Lorrain M, Baas H, Müller T, Riederer P.

J Neural Transm (Vienna). 2017 Mar 24. doi: 10.1007/s00702-017-1707-x. [Epub ahead of print] Review.

0

0

0

PUBMED

Dopaminergic Medication Increases Reliance on Current Information in Parkinson's Disease.

Vilares I, Kording KP.

Nat Hum Behav. 2017 Aug;1(8):0129. doi: 10.1038/s41562-017-0129. Epub 2017 Jul 17.

0

0

0

PUBMED

Dopamine-dependent changes of cortical excitability induced by transcranial static magnetic field stimulation in Parkinson's disease.

Dileone M, Carrasco-López MC, Segundo-Rodriguez JC, Mordillo-Mateos L, López-Ariztegui N, Alonso-Frech F, Catalan-Alonso MJ, Obeso JA, Oliviero A, Foffani G.

Sci Rep. 2017 Jun 28;7(1):4329. doi: 10.1038/s41598-017-04254-y.

0

0

0

PUBMED

Rotenone impairs hippocampal neuronal activity in a rat model of Parkinson's disease.

Darbinyan LV, Hambardzumyan LE, Simonyan KV, Chavushyan VA, Manukyan LP, Sarkisian VH.

Pathophysiology. 2017 Jan 22. pii: S0928-4680(16)30063-3. doi: 10.1016/j.pathophys.2017.01.001. [Epub ahead of print]

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy